Heme Oxygenase-1 As a Target for TGF-β in Kidney Disease

Overview

Journal Semin Nephrol

Specialty Nephrology

Date 2012 Jul 28

PMID 22835459

Citations 12

Authors

Abolfazl Zarjou

Anupam Agarwal

Affiliations

Soon will be listed here.

Abstract

Transforming growth factor-β (TGF-β) is a multifunctional regulatory cytokine that is implicated in a variety of kidney diseases, including diabetic nephropathy and chronic transplant rejection, where it promotes stimulation of the extracellular matrix deposition, cell proliferation, and migration. TGF-β exerts its biological functions largely via its downstream complex signaling molecules, Smad proteins. Paradoxically, TGF-β also is essential for normal homeostasis and suppression of inflammation through mechanisms that are yet to be fully elucidated. One feasible mechanism by which TGF-β may exert its beneficial properties is through induction of heme oxygenase-1 (HO-1). Induction of this redox-sensitive enzyme is known to be cytoprotective through its potent antioxidant, anti-inflammatory, and anti-apoptotic properties in different conditions including several kidney diseases. In this overview, recent advances in our understanding of the role of TGF-β in kidney disease, its molecular regulation of HO-1 expression, and the potential role of HO-1 induction as a therapeutic modality in TGF-β-mediated kidney diseases are highlighted.

Citing Articles

The different facets of heme-oxygenase 1 in innate and adaptive immunity.

Silva R, Vasconcelos L, Travassos L Cell Biochem Biophys. 2022; 80(4):609-631.

PMID: 36018440 DOI: 10.1007/s12013-022-01087-z.

Macrophages Protect Endometriotic Cells Against Oxidative Damage Through a Cross-Talk Mechanism.

Ogawa K, Liu T, Kawahara N, Kobayashi H Reprod Sci. 2022; 29(8):2165-2178.

PMID: 35199318 DOI: 10.1007/s43032-022-00890-6.

Immunomodulatory Effects of Heme Oxygenase-1 in Kidney Disease.

Li Y, Ma K, Han Z, Chi M, Sai X, Zhu P Front Med (Lausanne). 2021; 8:708453.

PMID: 34504854 PMC: 8421649. DOI: 10.3389/fmed.2021.708453.

Heme Burden and Ensuing Mechanisms That Protect the Kidney: Insights from Bench and Bedside.

Balla J, Zarjou A Int J Mol Sci. 2021; 22(15).

PMID: 34360940 PMC: 8347331. DOI: 10.3390/ijms22158174.

The Cross-Link between Ferroptosis and Kidney Diseases.

Wang J, Liu Y, Wang Y, Sun L Oxid Med Cell Longev. 2021; 2021:6654887.

PMID: 34007403 PMC: 8110383. DOI: 10.1155/2021/6654887.

References

Shute J, Marshall L, Bodey K, Bush A . Growth factors in cystic fibrosis - when more is not enough. Paediatr Respir Rev. 2003; 4(2):120-7. DOI: 10.1016/s1526-0542(03)00028-9. View

Ots M, Pechter U, Tamm A . Characteristics of progressive renal disease. Clin Chim Acta. 2000; 297(1-2):29-41. DOI: 10.1016/s0009-8981(00)00231-x. View

Hyytiainen M, Penttinen C, Keski-Oja J . Latent TGF-beta binding proteins: extracellular matrix association and roles in TGF-beta activation. Crit Rev Clin Lab Sci. 2004; 41(3):233-64. DOI: 10.1080/10408360490460933. View

Correa-Costa M, Semedo P, Monteiro A, Silva R, Pereira R, Goncalves G . Induction of heme oxygenase-1 can halt and even reverse renal tubule-interstitial fibrosis. PLoS One. 2010; 5(12):e14298. PMC: 3001459. DOI: 10.1371/journal.pone.0014298. View

Zhang H, Podojil J, Chang J, Luo X, Miller S . TGF-beta-induced myelin peptide-specific regulatory T cells mediate antigen-specific suppression of induction of experimental autoimmune encephalomyelitis. J Immunol. 2010; 184(12):6629-36. PMC: 2882517. DOI: 10.4049/jimmunol.0904044. View

Derynck R, Zhang Y . Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature. 2003; 425(6958):577-84. DOI: 10.1038/nature02006. View

Hocevar B, Howe P . Analysis of TGF-beta-mediated synthesis of extracellular matrix components. Methods Mol Biol. 2000; 142:55-65. DOI: 10.1385/1-59259-053-5:55. View

Doi K, Akaike T, Fujii S, Tanaka S, Ikebe N, Beppu T . Induction of haem oxygenase-1 nitric oxide and ischaemia in experimental solid tumours and implications for tumour growth. Br J Cancer. 1999; 80(12):1945-54. PMC: 2363152. DOI: 10.1038/sj.bjc.6690624. View

Yamagishi S, Inagaki Y, Okamoto T, Amano S, Koga K, Takeuchi M . Advanced glycation end products inhibit de novo protein synthesis and induce TGF-beta overexpression in proximal tubular cells. Kidney Int. 2003; 63(2):464-73. DOI: 10.1046/j.1523-1755.2003.00752.x. View

10.

Hill-Kapturczak N, Chang S, Agarwal A . Heme oxygenase and the kidney. DNA Cell Biol. 2002; 21(4):307-21. DOI: 10.1089/104454902753759726. View

11.

Feng X, Derynck R . Specificity and versatility in tgf-beta signaling through Smads. Annu Rev Cell Dev Biol. 2005; 21:659-93. DOI: 10.1146/annurev.cellbio.21.022404.142018. View

12.

Schiffer M, Bitzer M, Roberts I, Kopp J, Ten Dijke P, Mundel P . Apoptosis in podocytes induced by TGF-beta and Smad7. J Clin Invest. 2001; 108(6):807-16. PMC: 200928. DOI: 10.1172/JCI12367. View

13.

Agarwal A, Balla J, Balla G, Croatt A, Vercellotti G, Nath K . Renal tubular epithelial cells mimic endothelial cells upon exposure to oxidized LDL. Am J Physiol. 1996; 271(4 Pt 2):F814-23. DOI: 10.1152/ajprenal.1996.271.4.F814. View

14.

Kelly D, Cox A, Tolcos M, Cooper M, Wilkinson-Berka J, Gilbert R . Attenuation of tubular apoptosis by blockade of the renin-angiotensin system in diabetic Ren-2 rats. Kidney Int. 2002; 61(1):31-9. DOI: 10.1046/j.1523-1755.2002.00088.x. View

15.

Abdel-Aziz M, el-Asmar M, El-Miligy D, Atta H, Shaker O, Ghattas M . Retrovirus-mediated human heme oxygenase-1 (HO-1) gene transfer into rat endothelial cells: the effect of HO-1 inducers on the expression of cytokines. Int J Biochem Cell Biol. 2003; 35(3):324-32. DOI: 10.1016/s1357-2725(02)00172-3. View

16.

Worou M, Belmokhtar K, Bonnet P, Vourch P, Machet M, Khamis G . Hemin decreases cardiac oxidative stress and fibrosis in a rat model of systemic hypertension via PI3K/Akt signalling. Cardiovasc Res. 2011; 91(2):320-9. DOI: 10.1093/cvr/cvr072. View

17.

Inguaggiato P, Croatt A, Haggard J, Alam J, Nath K . Cellular overexpression of heme oxygenase-1 up-regulates p21 and confers resistance to apoptosis. Kidney Int. 2001; 60(6):2181-91. DOI: 10.1046/j.1523-1755.2001.00046.x. View

18.

Rocco M, Chen Y, Goldfarb S, Ziyadeh F . Elevated glucose stimulates TGF-beta gene expression and bioactivity in proximal tubule. Kidney Int. 1992; 41(1):107-14. DOI: 10.1038/ki.1992.14. View

19.

Gagliardini E, Benigni A . Therapeutic potential of TGF-beta inhibition in chronic renal failure. Expert Opin Biol Ther. 2007; 7(3):293-304. DOI: 10.1517/14712598.7.3.293. View

20.

Rico M, Rough J, Del Carpio-Cano F, Kunapuli S, Dela Cadena R . The axis of thrombospondin-1, transforming growth factor beta and connective tissue growth factor: an emerging therapeutic target in rheumatoid arthritis. Curr Vasc Pharmacol. 2009; 8(3):338-43. DOI: 10.2174/157016110791112296. View